Related Experiment Video
Updated: Oct 22, 2025

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Factors Affecting In-stent Restenosis in Patients Undergoing Percutaneous Coronary Angioplasty
Mostafa Sajadian1, Ladan Alizadeh1, Mahmoud Ganjifard2
1Atherosclerosis Prevention Research Center, Department of Cardiovascular Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Iran.
Insights
In-stent restenosis (ISR) after percutaneous coronary angioplasty (PCI) is a challenge. Stent site, length, hypertension, and diabetes are probable factors influencing ISR, requiring further research into other risks.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Research
Background:
- Percutaneous coronary angioplasty (PCI) and stent implantation are standard treatments for coronary artery stenosis.
- In-stent restenosis (ISR) remains a significant clinical challenge following these procedures.
- The precise factors contributing to ISR are not fully elucidated, with conflicting evidence regarding coronary artery disease (CAD) factors.
Purpose of the Study:
- To conduct a comprehensive review of potential factors influencing in-stent restenosis (ISR) in patients who have undergone PCI.
- To synthesize current evidence on the relationship between various patient and procedural factors and the occurrence of ISR.
Main Methods:
- A narrative review methodology was employed.
- Extensive literature searches were performed across major scientific databases: PubMed, Web of Science, Scopus, and Google Scholar.
- The search covered publications from January 1, 1990, to July 30, 2017, with a rigorous screening process resulting in the selection of 39 relevant papers.
Main Results:
- The analysis identified the anatomical site and length of the implanted stent as highly probable factors associated with ISR.
- Hypertension and diabetes mellitus were also confirmed as significant contributing factors to ISR.
- The review highlighted the need for further investigation into other potential risk factors.
Conclusions:
- Stent characteristics (site and length) and patient comorbidities (hypertension, diabetes) are key factors implicated in ISR development.
- Additional research is warranted to explore the impact of genetic factors, obesity, chronic infections, and glycemic control (e.g., Hemoglobin A1C) on ISR.
Abstract:
Percutaneous coronary angioplasty (PCI) and stent implantation are the most common therapeutic strategies for coronary artery stenosis; however, in-stent restenosis (ISR) is one of its important challenges. Although in some studies, coronary artery disease (CAD) factors are deemed to be the causes of ISR, in some others, the relationship between CAD factors and ISR are not observed. Over the past ten years, there has been no review article on factors affecting the ISR. This article aimed to review the possible factors affecting ISR in patients undergoing PCI. This narrative review study was conducted on PubMed, Web of Science, Scopus, and Google Scholar databases between 1 January 1990 and 30 July 2017. After initial screening of 1728 retrieved articles, 1401 articles were excluded to due irrelevancy to the review; and finally, 39 papers were selected for data collection. Our study results showed that the site and length of implanted stent, hypertension and diabetes are the most probable factors affecting ISR. Further studies are required for evaluation of the effect of other possible risk factors such as genetic sequencing, obesity, chronic infections and hemoglobin A1C levels.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Angina IV: Management
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Angina II: Classification

